Cargando…

The role of public law-based litigation in tobacco companies’ strategies in high-income, FCTC ratifying countries, 2004–14

BACKGROUND: Tobacco companies use a host of strategies to undermine public health efforts directed to reduce and eliminate smoking. The success, failure and trends in domestic litigation used by tobacco companies to undermine tobacco control are not well understood, with commentators often assuming...

Descripción completa

Detalles Bibliográficos
Autores principales: Steele, Sarah L., Gilmore, Anna B., McKee, Martin, Stuckler, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072156/
https://www.ncbi.nlm.nih.gov/pubmed/26036703
http://dx.doi.org/10.1093/pubmed/fdv068
_version_ 1782461357955743744
author Steele, Sarah L.
Gilmore, Anna B.
McKee, Martin
Stuckler, David
author_facet Steele, Sarah L.
Gilmore, Anna B.
McKee, Martin
Stuckler, David
author_sort Steele, Sarah L.
collection PubMed
description BACKGROUND: Tobacco companies use a host of strategies to undermine public health efforts directed to reduce and eliminate smoking. The success, failure and trends in domestic litigation used by tobacco companies to undermine tobacco control are not well understood, with commentators often assuming disputes are trade related or international in nature. We analyse domestic legal disputes involving tobacco companies and public health actors in high-income countries across the last decade to ascertain the types of action and the success or failure of cases, develop effective responses. METHODS: WorldLii, a publicly available online law repository, was used to identify domestic court cases involving tobacco companies from 2004 to 2014, while outcome data from LexisNexis and Westlaw databases were used to identify appeals and trace case history. RESULTS: We identified six domestic cases in the UK, Australia and Canada, noting that the tobacco industry won only one of six cases; a win later usurped by legislative reform and a further court case. Nevertheless, we found cases involve significant resource costs for governments, often progressing across multiple jurisdictional levels. DISCUSSION: We suggest that, in light of our results, while litigation takes up significant time and incurs legal costs for health ministries, policymakers must robustly fend off suggestions that litigation wastes taxpayers' money, pointing to the good prospects of winning such legal battles.
format Online
Article
Text
id pubmed-5072156
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-50721562016-10-21 The role of public law-based litigation in tobacco companies’ strategies in high-income, FCTC ratifying countries, 2004–14 Steele, Sarah L. Gilmore, Anna B. McKee, Martin Stuckler, David J Public Health (Oxf) Original Article BACKGROUND: Tobacco companies use a host of strategies to undermine public health efforts directed to reduce and eliminate smoking. The success, failure and trends in domestic litigation used by tobacco companies to undermine tobacco control are not well understood, with commentators often assuming disputes are trade related or international in nature. We analyse domestic legal disputes involving tobacco companies and public health actors in high-income countries across the last decade to ascertain the types of action and the success or failure of cases, develop effective responses. METHODS: WorldLii, a publicly available online law repository, was used to identify domestic court cases involving tobacco companies from 2004 to 2014, while outcome data from LexisNexis and Westlaw databases were used to identify appeals and trace case history. RESULTS: We identified six domestic cases in the UK, Australia and Canada, noting that the tobacco industry won only one of six cases; a win later usurped by legislative reform and a further court case. Nevertheless, we found cases involve significant resource costs for governments, often progressing across multiple jurisdictional levels. DISCUSSION: We suggest that, in light of our results, while litigation takes up significant time and incurs legal costs for health ministries, policymakers must robustly fend off suggestions that litigation wastes taxpayers' money, pointing to the good prospects of winning such legal battles. Oxford University Press 2016-09 2016-10-17 /pmc/articles/PMC5072156/ /pubmed/26036703 http://dx.doi.org/10.1093/pubmed/fdv068 Text en © The Author 2015. Published by Oxford University Press on behalf of Faculty of Public Health. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Steele, Sarah L.
Gilmore, Anna B.
McKee, Martin
Stuckler, David
The role of public law-based litigation in tobacco companies’ strategies in high-income, FCTC ratifying countries, 2004–14
title The role of public law-based litigation in tobacco companies’ strategies in high-income, FCTC ratifying countries, 2004–14
title_full The role of public law-based litigation in tobacco companies’ strategies in high-income, FCTC ratifying countries, 2004–14
title_fullStr The role of public law-based litigation in tobacco companies’ strategies in high-income, FCTC ratifying countries, 2004–14
title_full_unstemmed The role of public law-based litigation in tobacco companies’ strategies in high-income, FCTC ratifying countries, 2004–14
title_short The role of public law-based litigation in tobacco companies’ strategies in high-income, FCTC ratifying countries, 2004–14
title_sort role of public law-based litigation in tobacco companies’ strategies in high-income, fctc ratifying countries, 2004–14
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072156/
https://www.ncbi.nlm.nih.gov/pubmed/26036703
http://dx.doi.org/10.1093/pubmed/fdv068
work_keys_str_mv AT steelesarahl theroleofpubliclawbasedlitigationintobaccocompaniesstrategiesinhighincomefctcratifyingcountries200414
AT gilmoreannab theroleofpubliclawbasedlitigationintobaccocompaniesstrategiesinhighincomefctcratifyingcountries200414
AT mckeemartin theroleofpubliclawbasedlitigationintobaccocompaniesstrategiesinhighincomefctcratifyingcountries200414
AT stucklerdavid theroleofpubliclawbasedlitigationintobaccocompaniesstrategiesinhighincomefctcratifyingcountries200414
AT steelesarahl roleofpubliclawbasedlitigationintobaccocompaniesstrategiesinhighincomefctcratifyingcountries200414
AT gilmoreannab roleofpubliclawbasedlitigationintobaccocompaniesstrategiesinhighincomefctcratifyingcountries200414
AT mckeemartin roleofpubliclawbasedlitigationintobaccocompaniesstrategiesinhighincomefctcratifyingcountries200414
AT stucklerdavid roleofpubliclawbasedlitigationintobaccocompaniesstrategiesinhighincomefctcratifyingcountries200414